Halozyme (HALO) CEO Helen Torley Exercises Options and Sells 60,000 Shares

What Happened

• Helen Torley, President & CEO of Halozyme Therapeutics (HALO), exercised 60,000 stock options (three exercises of 20,000 each) at an exercise price of $18.41 per share (total cost $1,104,600) on Sept 9–11, 2026, and sold the resulting 60,000 shares in multiple open-market transactions the same days for aggregate proceeds of about $6,436,710. The insider thus acquired shares by exercising options (transaction code M) and disposed of those shares by sale (transaction code S).

Key Details

• Transaction dates: Sept 9–11, 2026. Sales executed across those three days at prices roughly in the $106.36–$108.29 range (weighted-average group prices reported; see footnotes for ranges).
• Shares exercised/acquired: 60,000 (20,000 each on Sept 9, 10, 11) at $18.41 ($368,200 each; $1,104,600 total).
• Shares sold/disposed: 60,000 total; total proceeds ≈ $6,436,710 (individual sales listed by share count and proceeds in the filing).
• Net cash (proceeds minus exercise cost): roughly $5.33M before fees/taxes.
• Footnotes: Sales were made under a Rule 10b5-1 trading plan adopted Dec 3, 2025 (F1). Sales reported as weighted-average prices with ranges provided in the filing (F2–F7). Options linked to a grant dated Feb 14, 2018 with a standard 4-year vesting schedule (F8).
• Shares owned after the transactions are not specified in the provided excerpt of the filing.
• Filing: Form 4 filed Sept 11, 2026 (covering Sept 9–11 trades); no late-filing indication in the provided data.

Context

• This pattern (exercise of options followed by same-day sales) is common for executives using exercised shares to cover the exercise price and tax withholding or to follow a pre-arranged 10b5-1 plan. It is a disposition of shares rather than an outright purchase signal; purchases generally carry more positive informational weight for investors.
• Transaction codes: M = option exercise/conversion; S = open-market sale. The 10b5-1 plan note means trades were pre-authorized and scheduled.